Media coverage
1
Media coverage
Title Sen-Jam Pharmaceutical Opens Enrollment For Patients In Their COVID Therapy Phase 2 Clinical Trial In Nepal And Engages With Strategic Investor For Worldwide Distribution' Media name/outlet MENAFN -Press Releases (English) Country/Territory Jordan Date 6/05/22 Persons Alex Limkaken